Avania, which is headquartered in the Netherlands, has acquired San Jose, California-based MAXIS.
MAXIS’ clients will benefit from Avania’s international footprint, gaining access to the company’s network in the U.S., EU and Australia. Avania brings enhanced services to the combined company — including biostatistics, data analytics and medical writing. Terms of the deal were not disclosed.
Avania is a contract research organization with specialized expertise in medical devices, novel technology and combination products. It advances products from feasibility through post-approval trials in analytics, clinical trials, consulting, regulatory and reimbursement.
MAXIS is a medical technology development service provider with expertise in pre-clinical engineering, design validation and verification, regulatory affairs, field clinical services and trial management.
According to data captured in the LevinPro HC database, this acquisition represents the 17th Medical Devices deal of 2023. There were 121 Medical Devices transactions posted in 2022.
